AS
Anar Swapnil Shah
About Anar Swapnil Shah
Data last updated:
Anar Swapnil Shah is a Director at Remus Pharmaceuticals Limited (since 2020), Designated Partner at Espee Therapeutics Llp (since 2016) and Director at Renosen Pharmaceuticals Private Limited (since 2019), and holds 6 more current directorships. The companies operate in Trading, Pharma and Business Outsourcing. The 4 current companies with reported revenue have a combined latest revenue of ₹647 Cr; the largest is Remus Pharmaceuticals Limited at ₹625 Cr (FY 2025). Earlier, Anar Swapnil Shah was a Designated Partner at Fifth Gear Fitness Llp (2015–2024) and Director at Senores Pharmaceuticals Limited (2017–2023) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Dec 2020 | 2015 | ₹625 Cr (FY 2025) | Active | |
| Designated Partner | 25 Nov 2016 | 2016 | ₹13.65 Cr (FY 2021) | Active | |
| Director | 22 May 2019 | 2019 | ₹7.36 Cr (FY 2025) | Active | |
| Designated Partner | 03 May 2019 | 2019 | ₹45 Lakh (FY 2022) | Active | |
| Director | 25 Nov 2025 | 2025 | Active | ||
| Director | 31 Jul 2025 | 2025 | Active | ||
| Director | 24 Jul 2025 | 2025 | Active | ||
| Director | 30 Jul 2020 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 08 Jul 2015 | 2015 | Active | ||
| Director | 26 Dec 2017 | 2017 | ₹418 Cr (FY 2025) | Active | |
| Designated Partner | 13 Aug 2018 | 2018 | Strike Off | ||
| Additional Director | 17 Jul 2014 | 2012 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anar Swapnil Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anar Swapnil Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anar Swapnil Shah
Anar Swapnil Shah currently holds 9 directorships: Remus Pharmaceuticals Limited (Director, since 30 Dec 2020, revenue ₹625 Cr (FY 2025)); Espee Therapeutics Llp (Designated Partner, since 25 Nov 2016, revenue ₹13.65 Cr (FY 2021)); Renosen Pharmaceuticals Private Limited (Director, since 22 May 2019, revenue ₹7.36 Cr (FY 2025)); Aelius Projects Llp (Designated Partner, since 03 May 2019, revenue ₹45 Lakh (FY 2022)); Senores Foundation (Director, since 25 Nov 2025); and 4 more.
Anar Swapnil Shah was first appointed on 17 Jul 2014 as Additional Director at Healthy Life Nutraceuticals Private Limited. The most recent appointment on record is 25 Nov 2025 at Senores Foundation.
The 4 current companies of Anar Swapnil Shah that report revenue have a combined latest revenue of ₹647 Cr: Remus Pharmaceuticals Limited ₹625 Cr (FY 2025); Espee Therapeutics Llp ₹13.65 Cr (FY 2021); Renosen Pharmaceuticals Private Limited ₹7.36 Cr (FY 2025); Aelius Projects Llp ₹45 Lakh (FY 2022).
Anar Swapnil Shah held 4 earlier board appointments: Fifth Gear Fitness Llp (Designated Partner, 08 Jul 2015 to 13 Jun 2024); Senores Pharmaceuticals Limited (Director, 26 Dec 2017 to 03 Nov 2023); Sumer Enterprises Llp (Designated Partner, from 13 Aug 2018); Healthy Life Nutraceuticals Private Limited (Additional Director, from 17 Jul 2014).
The current boards of Anar Swapnil Shah's companies include Arpit Deepakkumar Shah (Remus Pharmaceuticals Limited), Ashutosh Naginbhai Valani (Remus Pharmaceuticals Limited), Balwant Purohit (Remus Pharmaceuticals Limited), Bhavik Rashmikant Shah (Remus Pharmaceuticals Limited), Deval Bakulkumar Patel (Remus Pharmaceuticals Limited), Roma Vinodbhai Shah (Remus Pharmaceuticals Limited), among others.